Altamira Therapeutics Ltd. 20-F, filed May 16, 2023: IDEA: XBRL DOCUMENT
Taxation (Details) - Schedule of tax loss carry forwards - CHF (SFr) |
Dec. 31, 2022 |
Dec. 31, 2021 |
|---|---|---|
| Taxation (Details) - Schedule of tax loss carry forwards [Line Items] | ||
| Total tax loss carry-forwards | SFr 103,114,677 | SFr 109,855,150 |
| Within 1 year [Member] | ||
| Taxation (Details) - Schedule of tax loss carry forwards [Line Items] | ||
| Total tax loss carry-forwards | 27,956,899 | 28,909,896 |
| Between 1 and 3 years [Member] | ||
| Taxation (Details) - Schedule of tax loss carry forwards [Line Items] | ||
| Total tax loss carry-forwards | 31,668,498 | 50,673,943 |
| Between 3 and 7 years [Member] | ||
| Taxation (Details) - Schedule of tax loss carry forwards [Line Items] | ||
| Total tax loss carry-forwards | 41,797,708 | 29,007,049 |
| More than 7 years [Member] | ||
| Taxation (Details) - Schedule of tax loss carry forwards [Line Items] | ||
| Total tax loss carry-forwards | SFr 1,691,572 | SFr 1,264,262 |